Research What we do and how? Teams Meet our people News What's happening Photogallery Be in the picture Our Partners Join our projects Contacts Addresses, emails, phones…
Research Research
Laboratory Instruments Instruments purchased through European Regional Development Fund. CZ.02.1.01/0.0/0.0/15_003/0000495
Publications Articles published under the Project FIT
Patents And Inventions Patents filed under Project FIT
Teams Teams
Virology doc.RNDr. Daniel RŮŽEK, Ph.D.
Chemistry And Toxicology RNDr. Miroslav MACHALA, CSc.
Biotechnology and Immunology UPOL Prof. MUDr. Mgr. Milan RAŠKA, Ph.D.
News News
International Symposium - Innovative Health Care Technologies in Chemistry and Virology International Symposium​“Innovative Health Care Technologies in Chemistry and Virology”took place on 27.5.2019 at Veterinary Research Institute Brno, Czech Republic
Photogallery Photogallery
Laboratories and VRI campus Place for our scientists
Laboratory Instruments These instruments were financed by Regional Development Fund. CZ.02.1.01/0.0/0.0/15_003/0000495
Events photos Conferences, seminars, visits ...
You are here:
  • Home 
  • News 
  • Conference of Modern immunotherapy and gene therapy

Conference of Modern immunotherapy and gene therapy

On the occasion of the Opening ceremony for OP VVV Project FIT, we are holding a special conference on the main topics of modern immunotherapy and gene therapy. There will be presentations from Czech and Foreign Scientists who will be talking mainly about various aspects of gene and immunotherapies, methodological procedures and new technologies. Throughout current status and future trends will be discussed and examples presented of both research and active clinical development. This conference is held in association with the Czech Society for Gene and Cell Therapy (CS GBT).


Project FIT and CS GBT invites you

Ass. Prof. RNDr. Jaroslav Turánek, CSc. & Prof. Andrew David Miller


Date 12th October 2017
·        Start 9.00am
·        End 4:00pm


Large Lecture Room, 1st Floor, Building No.1 Veterinary Research Institute, v. v. i.
Hudcova 296/70, 621 00 Brno, Czech Republic




Session 1 Fundamentals in immunology and therapy
9.00 am Heinrich Haas      
BioNTech RNA Pharmaceuticals GmbH, An der Goldgrube 12, D-55131 Mainz, Germany
To be announced
9.25 am Daniel Scherman
Director of CNRS, Unité de Technologies Chimiques et Biologiques pour la Santé (UTCBS)
Université Paris Descartes – Chimie ParisTech, CNRS UMR8258-U1022 Inserm, France
New development in plasmid optimization for gene therapy and vaccines
9.50 am Lei Fu
Laboratory of Medicinal Chemistry & Integrative Medicine, School of Pharmacy, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai, 200240, P.R.China
Introducing School of Pharmacy and my research on Cytochrome c Oxidase Inhibitiors in Shanghai Jiao Tong University
Break 10.15 – 10.45 am
Session 2 Fundamental tools to probe and to understand biological mechanisms
10.45 am Jan Krejsek
Head of the Department of Clinical Immunology and Allergology, Faculty of Medicine Charles University in Hradec Králové, Simkova 870, 500 03 Hradec Kralove, Czech Republic
Sterile inflammation, alarmins and the principle mechanism of adjuvant action
Sterile inflammation, the principle mechanism of alumn Al(OH)3 adjuvanicity.
11.10 am Nicole Meisner-Kober
Novartis Institutes for Biomedical Research, CH-4000 Basel, Switzerland
Cell entry routes of exosomes as a novel paradigm for therapeutic RNA and drug delivery
11.35 am Hana Španielová
Department of Genetics and Microbiology, Faculty of Natural Science, Charles University,
Viničná 5, 128 43 Prague 2, Czech Republic
Lunch 12.00 – 1.30pm
Session 3 Creating key technologies for therapy
1.30 pm Régis Tournebize
Imagopole et INSERM 1202, Institute Pasteur, 25-28 Rue du Dr Roux, 75015 Paris, France
To be announced
1.55 pm Nigel Temperton
Head of Viral Pseudotype Unit, Medway School of Pharmacy, University of Kent at Medway, Anson Building, Central Avenue, Chatham, Maritime, Chatham, Kent, ME4 4TB, United Kingdom
To be announced
Break 2.20 – 2.30 pm
Session 4 Translating breakthrough technologies for therapy to the clinic
2.30 pm Jeffrey Ulmer
Head of Preclinical R&D US, GlaxoSmithKline Vaccines, 14200 Shady Grove Rd, Rockville, MD 20850, USA
Vaccine technologies for the discovery and development of new vaccines
2.55 pm Petr Malý
Head of the Laboratory of Ligand Engineering, Institute of Molecular Genetics of the Czech Academy of Sciences, v. v. i., Vídeňská 1083, 142 20 Prague 4, Czech Republic
To be announced


Close 3.20 pm